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pulmonary Microembolism in the Canine Model: Report of a Pilot
Study

I

Brack A. Bivins, MD,* Robert P. Rapp, PharmD,^ and Richard M. BeU, MD*

i

Use of in-line final filters to prevent the infusion offoreign particulates has lowered the rates of
postinfusion phlebitis in several controlled studies. The systemic effect of particulate infusion,
however, has not been thoroughly studied. In this study. 12 mongrel dogs recovering from a right
pneumonectomy were studied following infusion of various-sized particulates. Ten ofthe dogs were
infused with either 10 or 40 million, 9 or 25 \x.m. latex particles. The remaining two dogs were control
animals. Hemodynamic parameters were monitored in each animal. At death or 72 hours following
particle injection, the left lung was examined grossly and histologically. Changes in hemodynamic
parameters were not seen. Three of the dogs became clinically ill 48 hours following microsphere
injection. All dogs injected with particles had multiple discrete punctate areas of hemorrhagic
pulmonary infarction. The control dogs showed no sign of clinical illness or pulmonary injury. More
sophisticated animal and human studies are required to fully determine the physiologic effect of
injected particles. (Henry Ford Hosp Med J 1986;34:109-12)

se offinalin-line filters to prevent the infusion of foreign
particulates (in the size range of 1 to 25 ixm) present in intravenous (IV) solutions, dmgs, and infusion sets continues to
be controversial (1). The local effect of particulate infusion appears to be an increased rate of postinfusion phlebitis, as several
well-controlled double-blind studies with large numbers of patients have documented (2-8) (Table). Falchuk et al (8) recently
demonstrated that postinfusion phlebitis rates double at the end
of 72 hours when filters are not used.
The effect of injected particulates on tissues away from the
injection site and/or the systemic effects of these particulates
have not been studied thoroughly, and most published reports
consist of case reports of some specific adverse effect (9-12).
Animal studies have been published that give some insight into
the systemic distribution of injected particles (10,13-16).
Experimental work to date has focused on the distribution and
clinical effects of infused particles in healthy dogs. However,
the pulmonary reserve of the dog is quite good, and the lack of
changes seen in clinical parameters may not accurately reflect
the susceptibility of clinically ill patients to the infusion of large
numbers of particles during a prolonged hospitalization. In an
attempt to more closely mimic the clinical situation, we have
evaluated the effect of particulate infusion in a "compromised"
animal model with decreased pulmonary reserve during its recovery from surgery.

U

Table
Summary of Studies of the Effect of In-line Filtration
on the Incidence of Postinfusion Phlebitis
Author
Ryan et al (2)
DeLuca et al (3)
Maddox et al (4)
Evans et al (5)
Rusho and Bair (6)
Allcutt et al (7)
Falchuk et al (8)

Year

No.

Phlebitis,
Filter

Phlebitis,
No Filter

1973
1975
1977
1976
1979
1983
1985

100
146
120
.50
150
194
541

2%
12%
20%
8%
6%
9%
25%

45%
61%
60%
56%
27%
24%
58%

be magnified. Before initiation of the embolism protocol, each
dog was noted to be healthy and its thoracotomy wound well
healed.
For the embolization protocol, the dogs were anesthetized
with thiopental sodium intubated and ventilated with a volume
piston-type respirator. A Swan-Ganz triple lumen thermal dilution catheter was placed via a right intemal jugular cutdown.
Accurate placement was confirmed by wave pressure tracing,
which showed a wedge position in the right pulmonary artery.
The right femoral artery was cannulated for pressure monitoring
of systemic pressure via a 'Walthem strain gauge transducer connected to a Gilsen recorder The right femoral vein also was cannulated to allow a site for supplemental anesthesia as needed and
for venous sampling.

Materials and Methods

I'Paiii

Twelve mongrel dogs weighing between 15 and 25 kg were
selected for these acute experiments. These dogs underwent a
left pneumonectomy two weeks before the planned embolism
experiments. This was carried out to reduce the pulmonary vascular reserve of the animals so that any measurable effects could
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The animals were allowed to stabilize before obtaining baseline arterial blood pressure, pulse, arterial blood gases, pulmonary artery pressure, right atrial pressure, pulmonary capillary
wedge pressure, and cardiac output via thermal dilution technique. Following microsphere embolization, these measurements were repeated at 15, 30, 45, and 60 minute intervals
following embolization.
Two control animals received only saline infusions. Ten experimental animals were infused with nonreactive, nondegradable microspheres manufactured by the Minnesota Mining and
Manufacturing Company. Dogs #3,4, and 5 received I x 10' of
the 9 |xm microspheres infused over five minutes via the right
atrial port of the Swan-Ganz catheter; dogs #6 and 7 received 4
X 10' ofthe 9 |xm microspheres. Dogs #8 through 12 received
25 |xm microspheres overfiveminutes via the right atrial port of
the Swan-Ganz catheter, with dogs #8, 9, and 10 receiving 1 x
10'and dogs #11 and 12 receiving 4 x 10'of the microspheres.
Following completion of the one hour study period, the catheters were removed and the groin wounds sutured. The dogs
were allowed to recover with anticipation of repeating the measurements 72 hours postinfusion. However, dog #11 (who received 4 X 10' 25 iJim particles) died in less than 24 hours, and
dog #6 (who received 4 x 10' 9 |xm particles) died at 48 hours.
Shortiy after the deaths of dogs #6 and 11, and 72 hours following the recording period for the surviving animals (dogs # 1
through 5, 7 through 10, and 12), autopsies were performed and
the right lungs examined for gross evidence of injury.

Results
Data obtained from the 12 experimental animals were recorded for each group (control, 9 p,m/microspheres low dose, 9
p-m/microspheres high dose, 25 pim/microspheres low dose,
and 25 p,m/microspheres high dose).
The mean arterial pressure did not vary significantly between
groups during the one hour study period. There were no consistent changes in arterial blood gases (PO,, PCO,, pH) during the
one hour study period.
The two animals who received 25 p-m particles (dogs #8 and
II) had an early rise in mean pulmonary artery pressure (PAP)
which retumed toward baseline within one houn Dogs #3 and 4
who received 9 (xm particles had an eariy fall in PAP which also
retumed toward baseline by one hour. However, there were no
significant differences between the study groups.
The right atrial pressure changes were small; however, an
eariy rise in pressure was seen in the 25 (xm infused animals
(dogs #8 and 11), while the 9 |j,m infused animals (dogs #3 and
4) had an early fall in pressure. In both groups, these pressures
retumed toward normal by one hour. Again, there appeared to be
no significant differences between the groups. No changes occurred in the pulmonary wedge pressure during the one hour
study period. There were also no consistent changes in the cardiac output during the one hour study period.
The pulmonary artery resistance changes were small, but of
interest. An eariyrisein resistance was seen in the 25 |xm particle infused animals (dogs #8 and 11) compared to the fall in
resistance seen in the 9 |jt,m infused animals (dogs #3 and 4).
However, when the groups were compared, no significant differences were apparent. The changes seen in the total pulmo-
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nary resistance were similar to those noted with pulmonary artery resistance. Also, no consistent changes were seen in total
systemic resistance during the one hour study period.
Autopsy
Deaths—Dog #11 (4 X 10' 25 [xm particles) died 24 hours
postembolization. The lung had multiple areas of patchy mottiing consistent with hemorrhagic infarction, which was quite
severe. Dog #6 (4 x 10' 9 |xm particles) died 48 hours postembolization. The lung had multiple punctate areas consistent with
hemorrhagic infarction.
Survivors—For the control dogs (dogs #1 and 2), no gross
pulmonary pathology was noted. Dogs #8,9,10, and 12 (25 |xm
particles) were killed at 72 hours. The lungs were quite heavy
and appeared beefy with punctate hemorrhages. (Dog #8
appeared ill at 72 hours sample time.) A photomicrograph
from dog #12 demonstrates the microspheres lodged in a pulmonary arteriole with inflammatory response at 72 hours (see
Figure). Dogs #3, 4, 5, and 7 (9 (xm particles) were killed at 72
hours. The lungs were beefy with multiple small punctate
hemorrhages.

Discussion
In a series of investigations focusing on the consequences of
particulate contamination of parenteral fluids and drugs, we
have demonstrated that a) substantial numbers of particulates are
present in routinely administered fluids and dmgs (1), b) these
particulates appear to react specifically with vascular endothelium (17), c) the particulates significantly influence the incidence of infusion phlebitis (2-8), and d) the particulates can be
prevented from entering the patient by using a 0.22 or 0.45 |xm
in-line filter (3,18). Use offiltersto eliminate particulate administration to the patient receiving IV solutions and dmgs is associated with a significant decrease in the incidence of infusion
phlebitis, which results in decreased cost and discomfort with
IV therapy (18,19).
Although filtration was found to decrease the incidence of infusion phlebitis, it was also associated with a decrease in WBC
count and sedimentation rate when compared to patients receiving unfilteredfluids(3,18). The reduction in WBC count appears
to be a pure filtration phenomenon which is not associated with
the development of infusion phlebitis (15). In a series of animal
studies designed to investigate the systemic impact of particulate infusion manifested as an increased white count, sedimentation rate, and fever in humans, we have determined that a) inert
particulates cause leucocytosis when infused in the venous system of dogs (10,13); b) the distribution of infused particulates
varies with particle size (14); c) particulates smaller than 7 |xm
are phagocytized by white cells and retained within the liver and
spleen (14); d) small microspheres (3 |xm) tend to agglomerate
when administered intravascularly, presumably due to protein
adherence and a large surface-to-mass ratio (14); and e) particulates in the size range studied, from 3 to 25 jxm, are initially
retained in the lungs and slowly redistribute from the lungs to
other organs (14).
The infusion of even very small particulates (3 |xm) was associated with an immediate rise in WBCs (25% to 40% increase
within 2 hours) (13), and approximately 20% of 3 |xm micro-
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sphere particulates are retained in the lung during the first hours
following infusion (14). Thesefindingshave led to a series of
investigations studying the effect of microsphere particulate embolization on the canine lung. The initial studies focused on the
immediate postinfusion period (up to four hours postinfusion) in
an intact animal with no significant changes in either hemodynamics or histology being found. The lack of observable response was attributed to the enormous pulmonary reserve in the
dog(10,13,14).
This second series of experiments was undertaken to investigate the impact of microsphere particulate embolization in aninjais with depletion of pulmonary reserve by surgical excision
ofone lung. In these animals, as well, no acute hemodynamic
changes were observed even with doses of 40 x 10' 25 |xm microspheres. These animals, however, did exhibit marked clinical
deterioration over the next 24 to 72 hours with death occurring in
33% of the studied animals within 48 hours. The surviving animals were killed at 72 hours and subsequently found to have
multiple punctate hemorrhagic pulmonary infarcts interpreted
as being secondary to the microsphere emboli.
Similarfindingshave been made in both animal and human
studies of macroparticulate infusions associated with multiple blood transfusions (20-28). Studies focusing on the first
24 hours following transfusion have had equivocal results
(21,22,26,27). Studies following either the experimental animals or patients up to 48 to 72 hours after transfusion have found

histologic and clinical changes (decreased POj and increased
dead space) consistent with a microembolic pulmonary injury
(20-26). Curiously, 20, 40, and 170 |xm blood filters have not
been consistently effective in preventing the transfusion-associated pulmonary injury (20,22,23,29,30). This failure has been
attributed to damage caused by particles small enough to pass
through the large pore-sized filters (20,30). It has also been
observed that blood filters begin to generate an increased
number of microparticulates after the passage of several units
of blood, thereby adding to the embolic load received by the
patient (20,30).
We feel that the available evidence supports the need for small
pore-sized filtration as a means of reducing both the incidence of
infusion phlebitis and the potential for pulmonary injury secondary to particulate embolism. The role of microparticulates as
the etiologic agent in pulmonary injury needs to be verified. The
nature and the time course of the microembolic lesion needs to
be further defined in the experimental animal with follow-up
studies to confirm thesefindingsin humans.
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Figure—Photomicrograph demonstrating microspheres lodged in pulmonary arteriole with inflammatory response
seen at 72 hrs.
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